During the recent session, Aptose Biosciences Inc (NASDAQ:APTO)’s traded shares were 6.4 million, with the beta value of the company hitting 1.14. At the last check today, the stock’s price was $0.14, reflecting an intraday loss of -44.06% or -$0.1. The 52-week high for the APTO share is $2.91, that puts it down -1978.57 from that peak though still a striking -64.29% loss since the share price plummeted to a 52-week low of $0.23. The company’s market capitalization is $3.71M, and the average intraday trading volume over the past 10 days was 0.32 million shares, and the average trade volume was 561.64K shares over the past three months.

Aptose Biosciences Inc (APTO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. APTO has a Sell rating from 0 analyst(s) out of 3 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 3 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.35.

Aptose Biosciences Inc (NASDAQ:APTO) trade information

Aptose Biosciences Inc (APTO) registered a -44.06% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -44.06% in intraday trading to $0.14, hitting a weekly high. The stock’s 5-day price performance is -62.60%, and it has moved by -64.55% in 30 days. Based on these gigs, the overall price performance for the year is -94.38%. The short interest in Aptose Biosciences Inc (NASDAQ:APTO) is 0.12 million shares and it means that shorts have 1.82 day(s) to cover.

Aptose Biosciences Inc (APTO) estimates and forecasts

Statistics show that Aptose Biosciences Inc has outperformed its competitors in share price, compared to the industry in which it operates. Aptose Biosciences Inc (APTO) shares have gone down -87.70% during the last six months, with a year-to-date growth rate more than the industry average at 65.44% against 17.90.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 10.18%. While earnings are projected to return 76.39% in 2024.

APTO Dividends

Aptose Biosciences Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Aptose Biosciences Inc (NASDAQ:APTO)’s Major holders

Aptose Biosciences Inc insiders own 15.87% of total outstanding shares while institutional holders control 16.68%, with the float percentage being 19.83%. DOHENY ASSET MANAGEMENT /CA is the largest shareholder of the company, while 31.0 institutions own stock in it. As of 2024-06-30, the company held over 50550.0 shares (or 0.3849% of all shares), a total value of $0.32 million in shares.

The next largest institutional holding, with 92.0 shares, is of CALDWELL SUTTER CAPITAL, INC.’s that is approximately 0.0007% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $70.0.

Also, the Mutual Funds coming in first place with the largest holdings of Aptose Biosciences Inc (APTO) shares are Fidelity NASDAQ Composite Index Fund and DFA Investment Dimensions-Canadian Small Company Series. Data provided on Sep 30, 2024 indicates that Fidelity NASDAQ Composite Index Fund owns about 2.16 shares. This amounts to just over 0.01 percent of the company’s overall shares, with a $300.0 market value. The same data shows that the other fund manager holds slightly less at 767.0, or about 0.00% of the stock, which is worth about $106.0.